USPTO serial 75187094
REVIA NALTREXONE HCI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 9, 1998
- Examiner
- LE, MARGARET
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with REVIA NALTREXONE HCI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
DuPont Merck Pharmaceutical Company, The
Wilmington, DE
Other trademarks owned by DuPont Merck Pharmaceutical Company, The
DuPont Merck Pharmaceutical Company, The
Wilmington, DE
Other trademarks owned by DuPont Merck Pharmaceutical Company, The
DuPont Merck Pharmaceutical Company, The
Wilmington, DE
Other trademarks owned by DuPont Merck Pharmaceutical Company, The
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
KAREN H KONDRAD
G MATHEW LOMBARD BRISTOL-MYERS SQUIBB COMPANY345 PARK AVENEW YORK, NY 10154UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | providing information and brochures to physicians and healthcare personnel to assist in counseling patients as part of a comprehensive treatment program for alcohol dependence | SECTION 8 - CANCELLED | Mar 13, 1995 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DuPont Merck Pharmaceutical Company, The
- Other trademarks owned by DuPont Merck Pharmaceutical Company, The
- Other trademarks owned by DuPont Merck Pharmaceutical Company, The
- Other trademarks in Class 042
- Similar marks named REVIA NALTREXONE HCI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 12, 2005 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jul 24, 2002 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 9, 1998 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 17, 1998 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 13, 1998 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 14, 1997 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 30, 1997 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 30, 1997 | DOCK | ASSIGNED TO EXAMINER | — |